WIPO

NY-based biotech platform Terran Biosciences announced the publication of an international PCT patent application covering what may be the first new salts, co-crystals and polymorphs of psilocybin in history. CEO Dr. Sam Clark stated the company believes the new forms of psilocybin “will...

New York-based therapeutics biotech platform Terran Biosciences published a new World International Patent Organization (WIPO) application under the Patent Cooperation Treaty (PCT) to protect its novel, non-hallucinogenic psychoplastogens inspired in DMT and ibogaine with improved drug...

Fully-integrated biopharma company Albert Labs International Corp.’s international patent application covering IP around a novel manufacturing technology for the production and scaling of fungi biomass yields including psilocybin has received preliminary acceptance by the World International...

Shares of Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) — which specializes in developing transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders — were trading in the green Thursday. The stock gained ground after the International Intellectual Property...